Market News & Trends
Abeona Therapeutics Announces Licensing of the AIM Next-Generation AAV Gene Therapy Vector Platform
Abeona Therapeutics Inc. recently announced the exclusive worldwide license of a next-generation gene therapy AAV capsid portfolio from University of North Carolina at Chapel Hill.…
Australian Pharmaceutical Market to Surpass $25 Billion
Australia’s pharmaceutical market is set to rise from just over $22.85 billion in 2016 to $25.2 billion by 2020, registering a compound annual growth rate…
Virtual Pharma Companies: The Future is Now
Virtual Pharma Companies: The Future is Now Virtual pharma companies are growing because the business model works. Experience and flexibility is key…
Voyager Therapeutics & CHDI Foundation Collaborate to Develop Novel Gene Therapy for Huntington’s Disease
Voyager Therapeutics, Inc. recently announced a research collaboration with CHDI Foundation, Inc. (CHDI) to advance Voyager’s VY-HTT01 program, an adeno-associated virus (AAV)-mediated gene-silencing therapy for…
Lonza to Offer Novel Anc-AAV Gene Therapy Technology Through Exclusive Licensing Agreement
Lonza Houston, Inc. and Massachusetts Eye and Ear have entered into a strategic agreement that provides customers the ability to in-license Anc80 and other Anc-AAVs…
Inovalon & MDLIVE Bring Real-Time Advanced Analytics to Telemedicine Marketplace
Inovalon recently announced a multi-year agreement with MDLIVE, a leading telehealth platform provider, to provide on-demand, real-time patient insights and analytics. The new capability will…
Geron Provides Update on Imetelstat Trials Being Conducted by Janssen
Geron Corporation recently provided updates on the clinical trials being conducted by Janssen Research & Development, LLC, of the telomerase inhibitor imetelstat. Planned internal reviews…
Dermira Acquires Option to License Exclusive Rights for up to Three Early Stage Programs from Takeda
Dermira, Inc. recently announced it has entered into an exclusive option and license agreement with Takeda Pharmaceutical Company Limited. Pursuant to the terms of the…
Catalent to Acquire Pharmatek, Adding Expanded Drug Development Services & Spray Drying Technology
Catalent, Inc. recently announced an agreement for Catalent, through its wholly owned subsidiary, Catalent Pharma Solutions, Inc., to acquire Pharmatek Laboratories, Inc., a West Coast,…
Amyris & Ginkgo Bioworks Complete Collaboration Agreement to Accelerate Commercialization of Bio-Based Products
Amyris, Inc., the industrial bioscience company, recently announced that it has completed a subsequent collaboration agreement with Ginkgo Bioworks, which is expected to be approved…
Voyager Therapeutics Licenses Novel Gene Therapy Capsids From the California Institute of Technology
Voyager Therapeutics, Inc., a clinical-stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system (CNS), recently announced a co-exclusive worldwide…
Epizyme Earns $6-Million Milestone Payment From GlaxoSmithKline
Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapeutics, recently announced it has earned a $6 million milestone payment from GlaxoSmithKline (GSK). The milestone…
Gerresheimer to Sell Life Science Research Business
In line with its strategy of focusing on packaging and device solutions for pharmaceutical customers, Gerresheimer recently announced that it is to sell its Life…
Bayer Clinches Monsanto With Improved $66-Billion Bid
German drugs and crop chemicals company Bayer has won over US seeds firm Monsanto with an improved takeover offer of around $66 billion, ending months…
Dipexium Pharmaceuticals Announces Issuance of Patent
Dipexium Pharmaceuticals, Inc. recently announced that the European Patent Office has issued a new Locilex patent in the European Union (EU). The patent claims are…
Crown Bioscience Launches New Translational Platforms
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance metabolic disease and oncology research, will be announcing the release…
Capsugel Investing in Enhanced Micronization Capacity & Capabilities
Capsugel, a global leader in delivering high-quality, innovative dosage forms and solutions, recently announced an expansion of its facility in Quakertown, PA, to meet increasing…
Boost Vaccination Data Encourage Continued Development of Parkinson's Vaccine
AFFiRiS AG recently announced results of AFF008A, a Phase I clinical trial to assess boost immunizations with AFFITOPE PD01A, an active vaccine against Parkinson's disease…
Fuji Health Science Announces Name Change
Fuji Health Science, Inc. recently announced that as of September 1, 2016, the name of the entity has become Fuji Chemical Industries USA, Inc. to…
Allergan Acquires Gene Therapy Company
Allergan plc recently announced it has acquired substantially all of the assets of RetroSense in an all-cash transaction. Under the terms of the transaction, Allergan…
